Clinical Trial Update: Naltrexone in the Treatment of Pyromania [Phase 2]

View source ↗

Summary

This clinical trial update notes that the Phase 2 study of naltrexone for pyromania has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyromania

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Minnesota | Conditions: Pyromania | Phase 2 | Status: WITHDRAWN